Clinical Trial Update: Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating medication integration for adolescents with co-occurring ADHD and substance use disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Substance Use Disorder

Snippet

Sponsor: The National Center on Addiction and Substance Abuse at Columbia University | Conditions: Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder | Phase 1 | Status: COMPLETED